Publication

Towards a standard diet-induced and biopsy-confirmed mouse model of non-alcoholic steatohepatitis: Impact of dietary fat source

World Journal of Gastroenterology 25(33):4904-4920, 2019

Boland ML, Oró D, Tølbøl KS, Thrane ST, Nielsen JC, Cohen TS, Tabor DE, Fernandes F, Tovchigrechko A, Veidal SS, Warrener P, Sellman BR, Jelsing J, Feigh M, Vrang N, Trevaskis JL, Hansen HH

Subjects
GAN DIO-NASH (GAN DIO-MASH) mouseTherapeutic AreaMouseGAN ob/ob-NASH (GAN ob/ob-MASH) mouseob/ob mouseMethod/EndpointSpeciesBody compositionBody weightBlood biochemistryBioinformaticsNon-alcoholic steatohepatitis/Metabolic dysfunction-associated steatohepatitis (NASH/MASH)Histopathology scoreIntraperitoneal glucose tolerance test (IPGTT)Image analysisImmunohistochemistryLiver biopsyLiver morphometryMicrobiomicsRNA sequencing

Share this page

Resource Library

Related resources
Publication
Hepatocyte mARC1 promotes fatty liver disease
Publication
Dual targeting of hepatic fibrosis and atherogenesis by icosabutate, an engineered eicosapentaenoic acid derivative
Publication
Incretin combination therapy for the treatment of non-alcoholic steatohepatitis
Poster
Reproducibility of therapeutic effects of resmetirom in the GAN diet-induced obese and biopsy-confirmed mouse model of MASH

For further information

Contact us

Gubra

Hørsholm Kongevej 11B
2970 Hørsholm
Denmark

+45 3152 ­2650

Back To Top